National Health Investors, Inc. (NYSE:NHI) Receives Average Rating of "Moderate Buy" from Brokerages

National Health Investors, Inc. (NYSE:NHI - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $83.5714.

Several equities research analysts have recently issued reports on NHI shares. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research report on Thursday, June 25th. BMO Capital Markets cut their target price on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research note on Monday, June 15th. Wells Fargo & Company cut their target price on shares of National Health Investors from $79.00 to $78.00 and set an "equal weight" rating for the company in a research note on Tuesday, September 1st. Truist Financial reduced their price target on shares of National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a report on Wednesday, September 2nd. Finally, Weiss Ratings cut shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday, June 12th.

Insider Activity at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 2.70% of the company's stock.

Institutional Trading of National Health Investors

Hedge funds have recently modified their holdings of the company. Renaissance Group LLC grew its holdings in shares of National Health Investors by 3.8% in the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust's stock valued at $245,000 after purchasing an additional 117 shares in the last quarter. Captrust Financial Advisors grew its stake in shares of National Health Investors by 1.7% in the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust's stock worth $680,000 after buying an additional 146 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of National Health Investors by 34.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock worth $51,000 after buying an additional 160 shares during the last quarter. Assetmark Inc. increased its holdings in shares of National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock worth $110,000 after buying an additional 161 shares during the last quarter. Finally, Inspire Investing LLC raised its position in shares of National Health Investors by 3.2% during the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust's stock valued at $510,000 after buying an additional 198 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

NYSE NHI opened at $70.90 on Tuesday. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. National Health Investors has a twelve month low of $67.94 and a twelve month high of $91.38. The business has a 50-day moving average price of $75.25 and a 200-day moving average price of $77.98. The firm has a market cap of $3.48 billion, a price-to-earnings ratio of 20.49, a price-to-earnings-growth ratio of 3.78 and a beta of 0.52.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company had revenue of $121.32 million for the quarter. During the same period last year, the business posted $1.22 EPS. The firm's revenue for the quarter was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities research analysts predict that National Health Investors will post 4.76 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors's payout ratio is 106.36%.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.